SELLAS Life Sciences Group (SLS) Free Cash Flow: 2011-2024
Historic Free Cash Flow for SELLAS Life Sciences Group (SLS) over the last 8 years, with Sep 2024 value amounting to -$7.8 million.
- SELLAS Life Sciences Group's Free Cash Flow fell 13.26% to -$7.8 million in Q3 2024 from the same period last year, while for Sep 2024 it was -$33.1 million, marking a year-over-year decrease of 4.21%. This contributed to the annual value of -$35.4 million for FY2024, which is 12.71% down from last year.
- SELLAS Life Sciences Group's Free Cash Flow amounted to -$7.8 million in Q3 2024, which was up 19.38% from -$9.7 million recorded in Q2 2024.
- In the past 5 years, SELLAS Life Sciences Group's Free Cash Flow ranged from a high of $3.4 million in Q4 2020 and a low of -$12.1 million during Q1 2023.
- For the 3-year period, SELLAS Life Sciences Group's Free Cash Flow averaged around -$7.6 million, with its median value being -$7.2 million (2022).
- As far as peak fluctuations go, SELLAS Life Sciences Group's Free Cash Flow crashed by 245.33% in 2021, and later spiked by 30.37% in 2022.
- Over the past 5 years, SELLAS Life Sciences Group's Free Cash Flow (Quarterly) stood at $3.4 million in 2020, then crashed by 245.33% to -$5.0 million in 2021, then dropped by 3.54% to -$5.2 million in 2022, then grew by 6.35% to -$4.8 million in 2023, then decreased by 13.26% to -$7.8 million in 2024.
- Its Free Cash Flow was -$7.8 million in Q3 2024, compared to -$9.7 million in Q2 2024 and -$10.8 million in Q1 2024.